Overview

The 17th Annual UCLA Liver Diseases Symposium will provide a state-of-the-art update and scientific exchange on prevalent liver diseases and their complications using a multi-disciplinary approach with hepatologists, radiologists and surgeons.

Target Audience

1. Diagnose and manage patients with advanced liver disease and be better able to prognosticate and risk stratify those patients for medical procedures.
2. Understand the current process of evaluation, listing and organ allocation in liver transplantation.
3. Identify the risks and benefits of interventional radiology (IR) procedures for the management and treatment of clinically significant portal hypertension in patients with advanced liver disease.
4. Use evidence-based recommendations in the evaluation and management of hepatocellular carcinoma (HCC).
5. Discuss the role of current and recently approved second line therapies in the treatment of primary biliary cholangitis (PBC).
6. Evaluate and properly stratify patients with metabolic dysfunctionassociated steatotic liver disease (ie, fatty liver), and develop tailored therapies to prevent disease progression.
7. Review treatment options for patients with alcohol hepatitis and optimal long-term care.
8. Identify the most common causes of drug induced liver injury (DILI) and learn to assess which cases are likely to resolve or progress.
9. Diagnose acute liver failure, risk stratify patients, and identify those likely to recover and those likely to require a liver transplant.

Accreditation

The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

The David Geffen School of Medicine at UCLA designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California State Board of Registered Nursing accepts courses approved for the AMA PRA Category 1 Credits^TM as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies.

The American Board for Transplant Certification (ABTC) has approved this educational offering for up to 4.25 Category One Continuing Education Points for Transplant Certification (CEPTCs).

Credits

AMA PRA Category 1 Credits™ (4.25 hours), Non-Physician Attendance (4.25 hours)

For more information click the REGISTER NOW button below